Cetirizine-induced downregulation of airway fibroblast proliferation and function: A rationale for a different approach to allergy treatment?

Immunology Letters

Volumn 72, Issue 1, 2000, Pages 31-34

  Cagnoni, Francesca ^a   Oddera, Susanna ^a   Semino, Claudia ^b   Mincarini, Marcello ^a   Melioli, Giovanni ^b   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Adhesion molecule; Antihistamine; Fibroblast; Proliferation

Indexed keywords

ANTIHISTAMINIC AGENT; CELL ADHESION MOLECULE; CETIRIZINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; THYMIDINE;

AIRWAY; ALLERGY; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTI-ALLERGIC AGENTS; CELL DIVISION; CETIRIZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FIBROBLASTS; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; NASAL MUCOSA;

EID: 0034599439     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(00)00151-6     Document Type: Article

References (24)

1. Holgate S.T., Church M.K., Howarth P.H., Simons F.E., Campbell A., Dunn N., Routledge P., Hindmarch I., Timmerman H., Camm J., Friedmann P., Canonica W., Scadding G., Devalia J., Renwick A. Clin. Exp. Allergy Suppl. 3:1999;IV-VI.
2. Cuss F.M. Clin. Exp. Allergy Suppl. 20:1999;54-59.
3. Ciprandi G., Passalacqua G., Canonica G.W. Clin. Exp. Allergy Suppl. 20:1999;49-53.
4. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., Azzarone B. Clin. Invest. 101:1998;2129-2139.
5. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Jasmin C., Canonica G.W., Azzarone B. Int. Immunol. 10:1998;1421-1433.
6. Bianco A., Sethi S.K., Allen J.T., Knight R.A., Spiteri M.A. Eur. Respir. J. 12:1998;619-626.
7. Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Marlin S.D., Springer T.A. Cell. 56:1989;849-853.
8. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A. et al. BMJ. 10:1995;1225-1229.
9. Canonica G.W., Ciprandi G., Pesce G.P., Buscaglia S., Paolieri F., Bagnasco M. Int. Arch. Allergy Immunol. 107:1995;99-102.
10. Ciprandi G., Pronzato C., Ricca V., Bagnasco M., Canonica G.W. J. Allergy Clin. Immunol. 99:1994;738-746.
11. Ciprandi G., Buscaglia S., Pesce G., Passalacqua G., Rihoux J.P., Bagnasco M., Canonica G.W. J. Allergy Clin. Immunol. 95:1995;612-621.
12. Fasce L., Ciprandi G., Pronzato C., Cozzani S., Tosca M.A., Grimaldi I., Canonica G.W. Int. Arch. Allergy Immunol. 109:1996;272-276.
13. Dykewicz M.S., Fineman S., Skoner D.P., Nicklas R., Lee R., Blessing-Moore J., Li J.T., Bernstein I.L., Berger W., Spector S., Schuller D. Ann. Allergy Asthma Immunol. 81:1998;478-518.
14. G. Passalacqua et al. Inhaled and nasal corticosteroids: safety aspects. EAACI Position Paper. Allergy, in press.
15. Ferlazzo G., Semino C., Quartarone G., Pietra G., Melioli G. Tissue Antigens. 50:1997;459-465.
16. Leonardi A., Radice M., Fregona I.A., Plebani M., Abatangelo G., Secchi A.G. Exp. Eye Res. 68:1999;739-746.
17. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., Chu H.W. Am. J. Respir. Crit. Care Med. 160:1999;1001-1008.
18. Ciprandi G., Tosca M., Ricca V., Passalacqua G., Riccio A.M., Bagnasco M., Canonica G.W. Clin. Exp. Allergy. 27:1997;1160-1166.
19. Caproni M., Palleschi G.M., Falcos D., Papi C., Lotti T. Int. J. Dermatol. 34:1995;510-513.
20. Redier H., Chanez P., De Vos C., Rifai N., Clauzel A.M., Michel F.B., Godard P. J. Allergy Clin. Immunol. 90:1992;215-224.
21. Koller M., Hilger R.A., Rihoux J.P., Konig W. Int. Arch. Allergy App. Immunol. 110:1996;52-56.
22. Canonica G.W., Pesce G., Ruffoni S., Buscaglia S., Boero F., Jing G., Rihoux J.P., Ciprandi G. Ann. Allergy. 68:1992;251-254.
23. Ciprandi G., Ricca V., Tosca M., Landi M., Passalacqua G., Canonica G.W. Allergy. 54:1999;358-365.
24. ETAC Study Group Allergic factors associated with the development of asthma and the influence of Cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETACearly treatment of the atopic child. Pediatr. Allergy Immunol. 9:1998;116-124.